4

OWNERSHIP DOCUMENT

Company: Tonix Pharmaceuticals Holding Corp.
Filed: May 11, 2016
Period of Report: May 11, 2016
Accession Number: 0001144204-16-100933

View Document ↗ View on SEC.gov ↗